World's Best Scientists 2026 revealed!

D-Index & Metrics

Biology and Biochemistry

D-Index
59
Citations
11654
World Ranking
12620
National Ranking
90

Klaus Elenius publication distribution in Biology and Biochemistry in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Biology and Biochemistry in 2026. The highlighted bar marks where Klaus Elenius sits on this spectrum.

47–56 publications: 8 scientists 57–66 publications: 35 scientists 67–76 publications: 106 scientists 77–86 publications: 231 scientists 87–96 publications: 414 scientists 97–106 publications: 546 scientists 107–116 publications: 704 scientists 117–126 publications: 849 scientists 127–136 publications: 980 scientists 137–146 publications: 942 scientists 147–156 publications: 969 scientists 157–166 publications: 950 scientists 167–176 publications: 951 scientists 177–186 publications: 915 scientists 187–196 publications: 787 scientists 197–206 publications: 841 scientists 207–216 publications: 735 scientists 217–226 publications: 709 scientists 227–236 publications: 651 scientists 237–246 publications: 605 scientists 247–256 publications: 510 scientists 257–266 publications: 524 scientists 267–276 publications: 434 scientists 277–286 publications: 418 scientists 287–296 publications: 350 scientists 297–306 publications: 363 scientists 307–316 publications: 315 scientists 317–326 publications: 296 scientists 327–336 publications: 261 scientists 337–346 publications: 240 scientists 347–356 publications: 219 scientists 357–366 publications: 197 scientists 367–376 publications: 154 scientists 377–386 publications: 161 scientists 387–396 publications: 155 scientists 397–406 publications: 145 scientists 407–416 publications: 124 scientists 417–426 publications: 112 scientists 427–436 publications: 132 scientists 437–446 publications: 116 scientists 447–456 publications: 99 scientists 457–466 publications: 81 scientists 467–476 publications: 91 scientists 477–486 publications: 80 scientists 487–496 publications: 80 scientists 497–506 publications: 60 scientists 507–516 publications: 36 scientists 517–526 publications: 46 scientists 527–536 publications: 54 scientists 537–546 publications: 44 scientists 547–556 publications: 43 scientists 557–566 publications: 43 scientists 567–576 publications: 42 scientists 577–586 publications: 25 scientists 587–596 publications: 34 scientists 597–606 publications: 23 scientists 607–616 publications: 33 scientists 617–626 publications: 31 scientists 627–636 publications: 27 scientists 637–646 publications: 25 scientists 647–656 publications: 28 scientists 657–666 publications: 34 scientists 667–676 publications: 18 scientists 677–686 publications: 16 scientists 687–696 publications: 10 scientists 697–706 publications: 12 scientists 707–716 publications: 21 scientists 717–726 publications: 12 scientists 727–736 publications: 12 scientists 737–746 publications: 10 scientists 747–756 publications: 7 scientists 757–766 publications: 13 scientists 767–776 publications: 15 scientists 777–786 publications: 13 scientists 787–796 publications: 9 scientists 797–806 publications: 9 scientists 807–816 publications: 7 scientists 817–826 publications: 4 scientists 827–836 publications: 9 scientists 837–846 publications: 7 scientists 847–856 publications: 3 scientists 857–866 publications: 5 scientists 867–876 publications: 5 scientists 877–886 publications: 11 scientists 887–896 publications: 3 scientists 897–906 publications: 4 scientists 907–916 publications: 7 scientists 917–926 publications: 5 scientists 927–936 publications: 6 scientists 937–946 publications: 6 scientists 947–956 publications: 3 scientists 957–966 publications: 7 scientists 967–976 publications: 2 scientists 977–986 publications: 2 scientists 987–996 publications: 1 scientists 997–1,006 publications: 5 scientists 1,007–1,016 publications: 2 scientists 1,017–1,026 publications: 2 scientists 1,027 publications: 1 scientists 1,028+ publications: 100 scientists
47 publications 1,028+

This scientist: 153 publications — 28th percentile

28% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,028 publications or more.

Klaus Elenius D-index placement in Biology and Biochemistry in 2026

The chart shows the D-index (discipline H-index) distribution of Biology and Biochemistry scientists ranked by Research.com in 2026. The highlighted bar marks where Klaus Elenius sits on this spectrum.

40–41 D-Index: 80 scientists 42–43 D-Index: 183 scientists 44–45 D-Index: 317 scientists 46–47 D-Index: 504 scientists 48–49 D-Index: 718 scientists 50–51 D-Index: 900 scientists 52–53 D-Index: 1,026 scientists 54–55 D-Index: 1,150 scientists 56–57 D-Index: 1,236 scientists 58–59 D-Index: 1,253 scientists 60–61 D-Index: 1,163 scientists 62–63 D-Index: 1,131 scientists 64–65 D-Index: 1,032 scientists 66–67 D-Index: 897 scientists 68–69 D-Index: 814 scientists 70–71 D-Index: 715 scientists 72–73 D-Index: 709 scientists 74–75 D-Index: 596 scientists 76–77 D-Index: 512 scientists 78–79 D-Index: 473 scientists 80–81 D-Index: 412 scientists 82–83 D-Index: 373 scientists 84–85 D-Index: 358 scientists 86–87 D-Index: 285 scientists 88–89 D-Index: 273 scientists 90–91 D-Index: 227 scientists 92–93 D-Index: 208 scientists 94–95 D-Index: 193 scientists 96–97 D-Index: 153 scientists 98–99 D-Index: 157 scientists 100–101 D-Index: 148 scientists 102–103 D-Index: 120 scientists 104–105 D-Index: 113 scientists 106–107 D-Index: 100 scientists 108–109 D-Index: 86 scientists 110–111 D-Index: 67 scientists 112–113 D-Index: 72 scientists 114–115 D-Index: 73 scientists 116–117 D-Index: 64 scientists 118–119 D-Index: 53 scientists 120–121 D-Index: 60 scientists 122–123 D-Index: 54 scientists 124–125 D-Index: 43 scientists 126–127 D-Index: 38 scientists 128–129 D-Index: 49 scientists 130–131 D-Index: 26 scientists 132–133 D-Index: 18 scientists 134–135 D-Index: 23 scientists 136–137 D-Index: 32 scientists 138–139 D-Index: 32 scientists 140–141 D-Index: 27 scientists 142–143 D-Index: 19 scientists 144–145 D-Index: 22 scientists 146–147 D-Index: 12 scientists 148–149 D-Index: 16 scientists 150–151 D-Index: 14 scientists 152–153 D-Index: 10 scientists 154–155 D-Index: 13 scientists 156–157 D-Index: 10 scientists 158–159 D-Index: 7 scientists 160–161 D-Index: 9 scientists 162–163 D-Index: 13 scientists 164–165 D-Index: 4 scientists 166 D-Index: 4 scientists 167+ D-Index: 98 scientists
40 D-Index 167+

This scientist: 59 D-Index — 38th percentile

38% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 167 D-Index or more.

Overview

Klaus Elenius is affiliated with the University of Turku in Finland. Their research primarily spans the fields of Biochemistry, Genetics and Molecular Biology, as well as Medicine. The scientific outputs include a considerable focus on Molecular Biology, Oncology, Pulmonary and Respiratory Medicine, Cancer Research, and Cell Biology.

The scientist's work addresses various main topics, prominently including HER2/EGFR in Cancer Research, Lung Cancer Treatments and Mutations, Cancer Genomics and Diagnostics, Cancer-related Molecular Pathways, Protein Tyrosine Phosphatases, Microtubule and Mitosis Dynamics, and Signaling Pathways in Disease.

The venues where Klaus Elenius has published repeatedly reflect their research interests. Frequent publication channels include bioRxiv (Cold Spring Harbor Laboratory) with six publications, Cancer Research with five, Cancers and Journal of Visualized Experiments with two publications each, and Human Molecular Genetics with one publication.

Key recent papers authored or co-authored by Klaus Elenius are:

  • Therapeutic Potential of Targeting the SUMO Pathway in Cancer, 2021, Cancers
  • Erbb4 regulates the oocyte microenvironment during folliculogenesis, 2020, Human Molecular Genetics
  • Structural Basis for the Functional Changes by EGFR Exon 20 Insertion Mutations, 2021, Cancers
  • The guanine nucleotide exchange factor VAV3 participates in ERBB4-mediated cancer cell migration, 2020, Journal of Biological Chemistry
  • DUSP6 inhibition overcomes neuregulin/HER3-driven therapy tolerance in HER2+ breast cancer, 2024, EMBO Molecular Medicine

Collaborations with several frequent co-authors have been significant in their research career. These co-authors include Kari J. Kurppa, Deepankar Chakroborty, Katri Vaparanta, Veera K. Ojala, and Mark S. Johnson.

Best Publications

  • Amplification of HER-2 in gastric carcinoma: association with Topoisomerase IIα gene amplification, intestinal type, poor prognosis and sensitivity to trastuzumab

    M. Tanner;M. Hollmén;T. T. Junttila;A. I. Kapanen

  • ACTIVATION OF HER4 BY HEPARIN-BINDING EGF-LIKE GROWTH FACTOR STIMULATES CHEMOTAXIS BUT NOT PROLIFERATION

    Klaus Elenius;Subroto Paul;Genève Allison;Jilin Sun

  • Signaling via ErbB2 and ErbB3 Associates with Resistance and Epidermal Growth Factor Receptor (EGFR) Amplification with Sensitivity to EGFR Inhibitor Gefitinib in Head and Neck Squamous Cell Carcinoma Cells

    Kaisa Erjala;Maria Sundvall;Teemu T. Junttila;Na Zhang

  • High frequency of BRAF V600E mutations in ameloblastoma

    Kari J Kurppa;Javier Catón;Peter R Morgan;Ari Ristimäki

  • Characterization of a novel cell line established from a patient with Herceptin-resistant breast cancer

    Minna Tanner;Anita I Kapanen;Teemu Junttila;Olayinka Raheem

  • Induced expression of syndecan in healing wounds.

    K Elenius;S Vainio;M Laato;M Salmivirta

  • A Novel Juxtamembrane Domain Isoform of HER4/ErbB4 ISOFORM-SPECIFIC TISSUE DISTRIBUTION AND DIFFERENTIAL PROCESSING IN RESPONSE TO PHORBOL ESTER

    Klaus Elenius;Gabriel Corfas;Subroto Paul;Caroline J. Choi

  • Syndecan from embryonic tooth mesenchyme binds tenascin.

    M Salmivirta;K Elenius;S Vainio;U Hofer

  • Cleavable ErbB4 isoform in estrogen receptor-regulated growth of breast cancer cells.

    Teemu T. Junttila;Maria Sundvall;Mikael Lundin;Johan Lundin

  • Characterization of a naturally occurring ErbB4 isoform that does not bind or activate phosphatidyl inositol 3-kinase.

    Klaus Elenius;Caroline J Choi;Subroto Paul;Eric Santiestevan

  • The epidermal growth factor receptor couples transforming growth factor-alpha, heparin-binding epidermal growth factor-like factor, and amphiregulin to Neu, ErbB-3, and ErbB-4.

    David J. Riese;Edward D. Kim;Klaus Elenius;Sharon Buckley;Sharon Buckley

  • ERBB Receptor Signaling Promotes Ependymoma Cell Proliferation and Represents a Potential Novel Therapeutic Target for This Disease

    Richard J. Gilbertson;Lyndsay Bentley;Roberto Hernan;Teemu T. Junttila

  • Proteolytic Cleavage and Phosphorylation of a Tumor-associated ErbB4 Isoform Promote Ligand-independent Survival and Cancer Cell Growth

    Jorma A. Määttä;Maria Sundvall;Teemu T. Junttila;Liisa Peri

  • A natural ErbB4 isoform that does not activate phosphoinositide 3-kinase mediates proliferation but not survival or chemotaxis.

    Varpu Kainulainen;Maria Sundvall;Jorma A. Määttä;Eric Santiestevan

  • Function of the syndecans--a family of cell surface proteoglycans.

    Klaus Elenius;Markku Jalkanen

  • Heparin-binding EGF-like growth factor interacts with mouse blastocysts independently of ErbB1: a possible role for heparan sulfate proteoglycans and ErbB4 in blastocyst implantation.

    B.C. Paria;K. Elenius;M. Klagsbrun;S.K. Dey

  • Role of ErbB4 in breast cancer

    Maria Sundvall;Kristiina Iljin;Sami Kilpinen;Henri Sara

  • Growth Factors Induce 3T3 Cells to Express bFGF-binding Syndecan*

    K Elenius;A Määttä;M Salmivirta;M Jalkanen

  • Binding of human syndecan to extracellular matrix proteins.

    K Elenius;M Salmivirta;P Inki;M Mali

  • Syndecan from embryonic tooth mesenchyme binds tenascin

    Markku Jalkanen;Markku Salmivirta;Seppo Vainio;Klaus Elenius

Frequent Co-Authors

Markku Jalkanen
Markku Jalkanen Faron Pharmaceuticals
Michael Klagsbrun
Michael Klagsbrun Boston Children's Hospital
Heikki Joensuu
Heikki Joensuu University of Helsinki
Jorma Isola
Jorma Isola Tampere University
Seppo Vainio
Seppo Vainio University of Oulu
Reidar Grénman
Reidar Grénman Turku University Hospital
Rami I. Aqeilan
Rami I. Aqeilan Hebrew University of Jerusalem
Daniel J. Leahy
Daniel J. Leahy Johns Hopkins University School of Medicine
Minna Tanner
Minna Tanner Tampere University
Guy A. Rouleau
Guy A. Rouleau Montreal Neurological Institute and Hospital

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring Biology and Biochemistry in the USA opens doors to a wide range of online degrees and career pathways. Many students with a background in life sciences are now choosing flexible study formats, especially to balance work and personal commitments.

Health and wellness fields are especially popular. Options like an online bachelor's degree in exercise science offer foundational knowledge in human physiology and movement. If you’re interested in the broader study of body mechanics, an online kinesiology degree could be a great fit. Both degrees can lead to rewarding roles in fitness, rehabilitation, or coaching.

For those wanting to move into advanced healthcare roles quickly, certificate programs are available. Some students choose the shortest pmhnp program to become a Psychiatric Mental Health Nurse Practitioner. Similarly, the 12-month fnp program online allows existing nurses to expand their skills in just a year.

These pathways highlight the evolving landscape of online science education and provide flexible options for building a successful health or science-focused career.

Best Scientists Citing Klaus Elenius

Trending Scientists

Recently Published Articles